Cue Biopharma Announces 1-for-30 Reverse Stock Split
Cue Biopharma will implement a 1-for-30 reverse stock split effective April 23, 2026, reducing outstanding shares from approximately 97.7 million to roughly 3.3 million. The primary goal of the split is to increase the per-share price to regain compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market.
Key figures
- Reverse split ratio
- 1-for-30
- Pre split shares outstanding
- 97.7 million
- Post split shares outstanding
- 3.3 million
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.